medigraphic.com
ISSN 1025-0255 (Electronic)

2013, Number 3

<< Back

AMC 2013; 17 (3)

Systematic revision of the effects of the reversed smoking habit on the oral mucosa

Ardila MCM, Jiménez GR, Álvarez ME

Language: Spanish
References: 39
Page: 336-346
PDF size: 63.31 Kb.


ABSTRACT

Background: It is been said that the reversed smoking habit intensifies the seriousness of the diseases of the oral mucosa and put people at serious risks regarding oral health.
Objective: to revise the scientific literature related to the diseases of the oral mucosa associated to the reversed smoking habit.
Method: a systematic revision of observational and experimental investigations published in the Medline-PubMed and SciELO data bases from 1960 to 2012 was made. Terms were used in different combinations: nicotinic stomatitis, reverse smoking, reverse smokers, oral cancer, oral premalignant lesions and tobacco. Series of cases, duplicated results due to combinations of search terms, non-available data, letters to the editor and historical revisions were excluded.
Results: in all the revised studies it was revealed that the reversed smoking habit is more frequent in women than in men. Twelve investigations showed association between the reversed smoking habit and carcinoma of the hard palate or microinvasive tumors. It was observed that inverted smokers are at more risk of presenting blotches and red areas in the palate, as well as leukoplakias and carcinomas. The estimated risk of presenting carcinoma of the hard palate was 132 times higher in women that have the reverse smoking habit. Mortality rates set by age were almost twice higher for reverse smokers compared to non-smokers.
Conclusions: reversed smoking habit is associated to oral cancer and to other advanced diseases of the oral mucosa. Intervention studies should be conducted in order to try to persuade populations to quit smoking.


REFERENCES

  1. Quigley LF, Cobb CM, Hunt EE. Measurement of oral and burning zone temperatures during conventional and reverse cigarette smoking. Arch Oral Biol. 1965;10(1):35-44.

  2. Ortiz GM, Pierce AM, Wilson DF. Palatal changes associated with reverse smoking in Filipino women. Oral Dis. 1996;2(3):232-7.

  3. Álvarez Gómez GJ, Álvarez Martínez E, Jiménez Gómez R, Mosquera Silva Y, Gaviria Núñez AM, Garcés Agudelo A, et al. Reverse smokers’s and changes in oral mucosa. Department of Sucre, Colombia. Med Oral Patol Oral Cir Bucal. 2008;13(1):E1-8.

  4. Mehta FS, Jalnawalla PN, Daftary DK, Gupta PC, Pindborg JJ. Reverse smoking in Andhra Pradesh, India: variability of clinical and histologic appearances of palatal changes. Int J Oral Surg. 1977;6(2):75-83.

  5. Ramulu C, Raju MV, Venkatarathnam G, Reddy CR. Nicotine stomatitis and its relation to carcinoma of the hard palate in reverse smokers of chuttas. J Dent Res. 1973;52(4):711-8.

  6. Gupta PC, Mehta FS, Pindborg JJ. Mortality among reverse chutta smokers in south India. Br Med J (Clin Res Ed). 1984;289(6449):865-6.

  7. Vargas-Ferreira F, Nedel F, Etges A, Gomes AP, Furuse C, Tarquinio SB. Etiologic factors associated with oral squamous cell carcinoma in non-smokers and non-alcoholic drinkers: a brief approach. Braz Dent J. 2012;23(5):586-90.

  8. Abrahao AC, Bonelli BV, Nunes FD, Dias EP, Cabral MG. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders. Braz Oral Res. 2011;25(1):34-41.

  9. Humayun S, Prasad VR. Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study. Natl J Maxillofac Surg. 2011;2(1):38-46.

  10. Quigley LF, Shklar G, Cobb CM. Reverse cigarette smoking in Caribbeans: clinical, histologic, and cytologic observations. J Am Dent Assoc. 1966;72(4):867-73.

  11. Mehta FS, Pindborg JJ, Gupta PC, Daftary DK. Epidemiologic and histologic study of oral cancer and leukoplakia among 50,915 villagers in India. Cancer. 1969;24(4):832-49.

  12. Reddy CR, Kameswari VR, Ramulu C, Reddy PG. Histopathological study of stomatitis nicotina. Br J Cancer. 1971;25(3):403-10.

  13. Reddy CR, Raju MV, Ramulu C, Reddy PG. Changes in the ducts of the glands of the hard palate in reverse smokers. Cancer. 1972;30(1):231-8.

  14. Mehta FS, Sahiar BE, Daftary DK, Gupta PC, Pindborg JJ. A correlative histocytological study of carcinoma and epithelial atypia of the palate among Indian reverse smokers. Br J Cancer. 1972;26(3):230-3.

  15. Reddy CR, Kameswari VR, Raju MV, Ramulu C. Microinvasive carcinoma of the hard palate. Br J Cancer. 1974;29(2):179-80.

  16. Reddy CR. Carcinoma of hard palate in India in relation to reverse smoking of chuttas. J Natl Cancer Inst. 1974;53(3):615-9.

  17. Pindborg JJ, Daftary DK, Mehta FS. A follow-up study of sixty-one oral dysplastic precancerous lesions in Indian villagers. Oral Surg Oral Med Oral Pathol. 1977;43(3):383-90.

  18. Gupta PC, Mehta FS, Daftary DK, Pindborg JJ, Bhonsle RB, Jalnawalla PN, et al. Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol. 1980;8(6):283-333.

  19. González Quintero JQ. Registry of squamous cell carcinoma in the regions of Cordoba and Sucre. Rev Fed Odontol Colomb. 1985;34(153):39-42.

  20. Gavarasana S, Susarla MD. Palatal mucosal changes among reverse smokers in an Indian village. Jpn J Cancer Res. 1989;80(3):209-11.

  21. Hedin C, Pindborg JJ, Daftary DK, Mehta FS. Melanin depigmentation of the palatal mucosa in reverse smokers: a preliminary study. J Oral Pathol Med. 1992;21(10):440-4.

  22. van der Eb MM, Leyten EM, Gavarasana S, Vandenbroucke JP, Kahn PM, Cleton FJ. Reverse smoking as a risk factor for palatal cancer: a cross-sectional study in rural Andhra Pradesh, India. Int J Cancer. 1993;54(5):754-8.

  23. Santana Garay JC. Atlas de patología del complejo bucal. La Habana: Científico Técnica; 1985.

  24. Hebert JR, Gupta PC, Bhonsle RB, Mehta H, Zheng W, Sanderson M, et al. Dietary exposures and oral precancerous lesions in Srikakulam District, Andhra Pradesh, India. Public Health Nutr. 2002;5(2):303-12.

  25. Rickert WS, Trivedi AH, Momin RA, Wagstaff WG, Lauterbach JH. Mutagenic, cytotoxic, and genotoxic properties of tobacco smoke produced by cigarillos available on the Canadian market. Regul Toxicol Pharmacol. 2011;61(2):199-209.

  26. Yauk CL, Williams A, Buick JK, Chen G, Maertens RM, Halappanavar S, et al. Genetic toxicology and toxicogenomic analysis of three cigarette smoke condensates in vitro reveals few differences among full-flavor, blonde, and light products. Environ Mol Mutagen. 2012;53(4):281-96.

  27. Guo X, Verkler TL, Chen Y, Richter PA, Polzin GM, Moore MM, et al. Mutagenicity of 11 cigarette smoke condensates in two versions of the mouse lymphoma assay. Mutagenesis. 2011;26(2):273-81.

  28. Combes R, Scott K, Dillon D, Meredith C, McAdam K, Proctor C. The effect of a novel tobacco process on the in vitro cytotoxicity and genotoxicity of cigarette smoke particulate matter. Toxicol In Vitro. 2012;26(6):1022-9.

  29. Kakde S, Bhopal RS, Jones CM. A systematic review on the social context of smokeless tobacco use in the South Asian population: implications for public health. Public Health. 2012;126(8):635-45.

  30. Li E, Trovato JA. New developments in management of oral mucositis in patients with head and neck cancer or receiving targeted anticancer therapies. Am J Health Syst Pharm. 2012;69(12):1031-7.

  31. Hillbertz NS, Hirsch JM, Jalouli J, Jalouli MM, Sand L. Viral and molecular aspects of oral cancer. Anticancer Res. 2012;32(10):4201-12.

  32. Terada T. Papillary squamous cell carcinoma of the mandibular gingiva. Int J Clin Exp Pathol. 2012;5(7):707-9.

  33. de Oliveira Semenzati G, de Souza Salgado B, Rocha NS, Michelin Matheus SM, de Carvalho LR, Garcia Martins RH. Histological and immunohistochemical study of the expression of p53 and ki-67 proteins in the mucosa of the tongue, pharynx and larynx of rats exposed to cigarette smoke. Inhal Toxicol. 2012;24(11):723-31.

  34. Visioli F, Lauxen IS, Sant'ana Filho M, Rados PV. Expression of the cell cycle regulation proteins p53 and p21WAF1 in different types of non-dysplastic leukoplakias. J Appl Oral Sci. 2012;20(3):369-75.

  35. Bascones-Martínez A, López-Durán M, Cano-Sánchez J, Sánchez-Verde L, Díez-Rodríguez A, Aguirre-Echebarría P, et al. Differences in the expression of five senescence markers in oral cancer, oral leukoplakia and control samples in humans. Oncol Lett. 2012;3(6):1319-25.

  36. Nasser W, Flechtenmacher C, Holzinger D, Hofele C, Bosch FX. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias. J Oral Pathol Med. 2011;40(8):629-35.

  37. Khan Z, Tiwari RP, Mulherkar R, Sah NK, Prasad GB, Shrivastava BR, et al. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Head Neck. 2009;31(8):1039-48.

  38. Health Quality Ontario. Population-based smoking cessation strategies: a summary of a select group of evidence-based reviews. Ont Health Technol Assess Ser. 2010;10(1):1-44.

  39. Antal M, Forster A, Zalai Z, Barabas K, Spangler J, Braunitzer G, et al. A video feedback-based tobacco cessation counselling course for undergraduates-preliminary results. Eur J Dent Educ. 2013;17(1):e166-72.




2020     |     www.medigraphic.com